Comparative Pharmacology
Head-to-head clinical analysis: HYDROXOMIN versus REDISOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDROXOMIN versus REDISOL.
HYDROXOMIN vs REDISOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. It also acts as a direct scavenger of cyanide ions by binding to them to form cyanocobalamin, which is excreted renally.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. It also binds to cyanide ions to form cyanocobalamin, which is excreted renally, thereby detoxifying cyanide.
100 mg intramuscularly or deep subcutaneously three times a week.
Cyanocobalamin 1000 mcg intramuscularly or subcutaneously once daily for 5-10 days, then 100-1000 mcg monthly for maintenance; intranasal: 500 mcg intranasally once weekly.
None Documented
None Documented
Terminal elimination half-life approximately 4-6 hours; may extend to 8-12 hours in moderate to severe renal impairment (CrCl <30 mL/min).
~50-100 minutes; prolonged in renal impairment
Primarily renal (80-90% unchanged) with minor biliary/fecal elimination (5-10%); total clearance ~150 mL/min.
Primarily renal (50-80% as unchanged drug); minimal biliary/fecal
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement